Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.43 |
| ▸ | KDM5A | P29375 | 3/20 | 0.41 |
| ▸ | PHF8 | Q9UPP1 | 3/20 | 0.41 |
| ▸ | KDM2A | Q9Y2K7 | 3/20 | 0.41 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.41 |
| ▸ | KDM4A | O75164 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2078513 | 1.00 | SIGMAR1 (0.56) | SIGMAR1CYP1A2EPHX1KDM5APHF8 | |
| Cyclohexane SCHEMBL11567704 | 1.00 | SIGMAR1 (0.56) | SIGMAR1CYP1A2EPHX1KDM5APHF8 | |
| SCHEMBL5313490 | 1.00 | SIGMAR1 (0.56) | SIGMAR1CYP1A2EPHX1KDM5APHF8 | |
| SCHEMBL1573054 | 1.00 | SIGMAR1 (0.56) | SIGMAR1CYP1A2EPHX1KDM5APHF8 | |
| SCHEMBL25310908 | 0.97 | SIGMAR1 (0.60) | SIGMAR1CYP1A2EPHX1KDM5APHF8 | |
| SCHEMBL1007122 | 0.97 | SIGMAR1 (0.60) | SIGMAR1CYP1A2EPHX1KDM5APHF8 | |
| SCHEMBL1006136 | 0.97 | SIGMAR1 (0.60) | SIGMAR1CYP1A2EPHX1KDM5APHF8 | |
| SCHEMBL330182 | 0.97 | SIGMAR1 (0.60) | SIGMAR1CYP1A2EPHX1KDM5APHF8 | |
| SCHEMBL1006265 | 0.97 | SIGMAR1 (0.60) | SIGMAR1CYP1A2EPHX1KDM5APHF8 | |
| SCHEMBL1006966 | 0.97 | SIGMAR1 (0.60) | SIGMAR1CYP1A2EPHX1KDM5APHF8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 649 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024258458-A1 | HALOGENATED OLEFIN-CONTAINING POLYURETHANE FOAM-FORMING COMPOSITIONS, RELATED FOAMS AND METHODS FOR THEIR PRODUCTION | COVESTRO LLC (US) | 2024-12-19 | — | — | WO | claimed |
| CN-118222171-A | Nanometer stamping adhesive for improving adhesive force of glass-based circuit and circuit manufacturing method based on glass substrate | 深圳市百柔新材料技术有限公司 | 2024-06-21 | — | — | CN | claimed |
| CN-117843581-A | Microsomal prostaglandin E synthase 1 inhibitor analogue and synthetic method thereof | 叶刚 | 2024-04-09 | — | — | CN | claimed |
| CN-115087710-B | Hydrophobic modified polyurethane thickener and preparation method thereof | 科莱恩国际有限公司 | 2024-03-01 | — | — | CN | claimed |
| CN-113035408-B | Solar cell grid line slurry and preparation method thereof, and solar cell | 深圳市百柔新材料技术有限公司 | 2024-02-02 | — | — | CN | claimed |
| US-20230192939-A1 | Hydrophobically Modified Polyurethane Thickener And Process For Its Preparation | CLARIANT INTERNATIONAL LTD. (CH) | 2023-06-22 | — | — | US | claimed |
| EP-4127080-A1 | HYDROPHOBICALLY MODIFIED POLYURETHANE THICKENER AND PROCESS FOR ITS PREPARATION | Clariant International Ltd (CH) | 2023-02-08 | — | — | EP | claimed |
| CN-115087710-A | Hydrophobically modified polyurethane thickener and preparation method thereof | 科莱恩国际有限公司 | 2022-09-20 | — | — | CN | claimed |
| WO-2021195934-A1 | HYDROPHOBICALLY MODIFIED POLYURETHANE THICKENER AND PROCESS FOR ITS PREPARATION | CLARIANT INTERNATIONAL LTD (CH) | 2021-10-07 | — | — | WO | claimed |
| CN-113035408-A | Solar cell grid line paste and preparation method thereof, and solar cell | 深圳市百柔新材料技术有限公司 | 2021-06-25 | — | — | CN | claimed |
| CN-108569872-A | A kind of protective materials and the application as building surface protective layer and reparation building corrosion location | 黄河勘测规划设计有限公司 | 2018-09-25 | — | — | CN | claimed |
| CN-108424020-A | A kind of method for modifying super hydrophobicity of mineral admixture | 黄河勘测规划设计有限公司 | 2018-08-21 | — | — | CN | claimed |
| CN-103962091-A | Method for separating EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) by using silver ion modified amino silica gel | UNIV DALIAN POLYTECHNIC | 2014-08-06 | — | — | CN | claimed |
| EP-1647541-B1 | Cyclohexanbutanol derivative and fragrance use thereof | INT FLAVORS & FRAGRANCES INC (US) | 2010-08-11 | — | — | EP | claimed |
| EP-1647541-A1 | Cyclohexanbutanol derivative and fragrance use thereof | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2006-04-19 | — | — | EP | claimed |
| US-6989052-B1 | Phase change ink printing process | XEROX CORPORATION (US) | 2006-01-24 | — | — | US | claimed |
| US-20060004123-A1 | PHASE CHANGE INK PRINTING PROCESS | XEROX CORPORATION | 2006-01-05 | — | — | US | claimed |
| US-6906013-B1 | Cyclohexanbutanol derivative and fragrance use thereof | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2005-06-14 | — | — | US | claimed |
| CN-1454897-A | Method for producing phosphorousphenate | BAYER AG (DE) | 2003-11-12 | — | — | CN | claimed |
| US-20030204116-A1 | Process for the production of phosphonium phenolates | BAYER AKTIENGESELLSCHAFT (DE) | 2003-10-30 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030204116-A1 | Process for the production of phosphonium phenolates | PHOSPHO1, PIP5K1C, PHYKPL | SIGMAR1 1847/4885CYP1A2 1673/4885EPHX1 1523/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.